|
|
||||||||
Rabkin et al. assessed 80 hospice-eligible ALS patients at monthly intervals until death or tracheostomy. Although transient depressive symptoms were observed, depressive disorders were uncommon (9% had symptoms consistent with major depression, 10% with minor depression). Rates did not increase as death approached. In monthly follow-up of 53 ALS patients who died, Albert et al. found that 10 (18.9%) expressed the wish to die and three (5.7%) requested sedatives explicitly to hasten dying. The wish to die was associated with pessimism, less comfort in religion, and greater hopelessness, but not with depression.
see pages 62 and 68
ALS, depression, and desire for a hastened death: (How) are they related?
Commentary by Timothy E. Quill, MD
Patients with ALS must have a high incidence of depression (Wouldn't you be depressed under these circumstances?), and certainly those who express a desire for a hastened death must have a high incidence of depression (No one in their right mind would make that choice.). These two pervasive myths are challenged in this issue of Neurology in two articles from the Eleanor & Lou Gehrig MDA/ALS Research Center in New York. The first article reports the results of prospective monthly depression assessments of 80 hospice-eligible ALS patients; the authors found that while transient episodes of depression occurred in 43%, only 9% of patients had sustained symptoms of major depression, and the incidence of depression did not significantly increase as death approached. The second article reports the frequencies of a genuine wish to die (18.9%) and of subsequent acts to hasten death (5.7%) in the 53 patients who died from the same cohort. These authors found that the wish to die correlated with pessimism, decreased comfort in religion, and hopelessness, but much less so with depression. The patients who hastened death reported decreased suffering and increased sense of control over disease during their final weeks. In an associated editorial, Olney and Lomen-Hoerth ask whether subtle cognitive impairment from unrecognized frontotemporal dementia might have confounded the picture.
Depression scales clearly need to be adjusted when they are applied to severely ill, potentially dying patients. Thinking about death and preparing for it are essential parts of this phase of life, and symptoms such as fatigue, anorexia, sleep disturbance, and poor concentration are common in the terminally ill, yet in unadjusted depression scales designed for physically healthy persons such features may overdiagnose depression. Similarly, the Beck Hopelessness Scale has items such as I can't imagine what my life would be like in 10 years, or The future seems vague and uncertain to me, or Things just won't work out the way I want them to, each of which assesses the responder's orientation toward the future, which takes on a different meaning when one has a severe progressive illness such as advanced ALS.1 It is not surprising that the authors found a high incidence of hopelessness in those ALS patients who had a strong wish for death, but depression, particularly when adjusted for suicidality, did not strongly correlate. The Mini-Mental Status examination is clearly inadequate to assess subtle cognitive impairment that may be present in ALS patients who appear cognitively intact.
Many ALS patients contemplate potentially hastening their death, and a majority endorse legalization of physician-assisted suicide.2 Yet contemplators must be distinguished from those who seriously consider the options, from those who genuinely explore the wish to die, from those who act on those feelings. The 5.7% who actively hastened death in this study were an interesting subgroup. None of these three patients used feeding tubes or ventilators, and none carried out physician-assisted suicide. Instead, "the hospice team titrated sedatives, progressing from oral to transdermal morphine preparations, usually for 23 days," presumably at the patient's request. This act would probably be considered a variant of "terminal sedation," with medication doses being increased until complete sedation is achieved, allowing the patient to escape from his or her suffering.3 This practice seems to be legally acceptable, though its moral status is currently being debated. We know there is tremendous variation in its availability, with a range of 0 to 50% of hospice deaths depending on the program.
One of the biggest challenges for clinicians caring for ALS patients who want to explore their end-of-life choices is to learn how to discuss potential last-resort options with them (table).3 Feeding tubes and mechanical ventilation are almost always part of the discussion, and we have found that having a willingness to discuss stopping them once started allows some patients who fear chronic dependence to try these treatments in a time-limited way that keeps them in control of the process. Sometimes knowledge that there could be an escape allows some patients to keep going in circumstances under which they would otherwise feel trapped. Assessing for depression is always a piece of the assessment puzzle, but as these two articles demonstrate, trying to understand the patient's dilemma and view of the present and future requires a much broader inquiry into existential and personal domains with which the patient is trying to come to grips.
|
References
Related Articles
This article has been cited by other articles:
![]() |
Y. Inui, H. Toyama, Y. Manabe, T. Sato, M. Sarai, K. Kosaka, N. Iwata, and K. Katada Evaluation of Probable or Possible Dementia with Lewy Bodies Using 123I-IMP Brain Perfusion SPECT, 123I-MIBG, and 99mTc-MIBI Myocardial SPECT J. Nucl. Med., October 1, 2007; 48(10): 1641 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. De las Heras, C. De Andres, N. Tellez, M. Tintore, and on behalf of the EMPATIE Study Group, Spain Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population Multiple Sclerosis, September 1, 2007; 13(8): 981 - 984. [Abstract] [PDF] |
||||
![]() |
N. Birbaumer and L. G. Cohen Brain-computer interfaces: communication and restoration of movement in paralysis J. Physiol., March 15, 2007; 579(3): 621 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
Letters to the editor Palliative Medicine, March 1, 2007; 21(2): 161 - 164. [PDF] |
||||
![]() |
M. Gourie-Devi and S. M. Albert Wish to die in end-stage ALS Neurology, January 2, 2007; 68(1): 79 - 79. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |